Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors

Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors

Bibliographic Details
Main Authors:	Marc S Weinberg, Adam J Weinberg, Dion H Zappe
Format:	Article
Language:	English
Published:	SAGE Publications 2000-09-01
Series:	Journal of the Renin-Angiotensin-Aldosterone System
Online Access:	https://doi.org/10.3317/jraas.2000.034

Similar Items

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers
by: Neil Poulter, et al.
Published: (2006-06-01)

Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes
by: Özlem Bozkurt, et al.
Published: (2009-06-01)

Blockers of the renin–angiotensin–aldosterone system: almost, but not yet, an absolute weapon against cardiovascular and renal diseases!
by: Bernard Waeber
Published: (2012-03-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Overview of Regulation of the Renin–Angiotensin–Aldosterone System
by: Akira Nishiyama, et al.
Published: (2010-01-01)

Combination of aliskiren with angiotensin-converting enzyme-inhibitor and angiotensin receptor blocker — mechanism of action
by: Luis M Ruilope
Published: (2008-03-01)

Synergistic inhibitory effect of angiotensin II receptor blocker and thiazide diuretic on the tissue renin-angiotensin-aldosterone system
by: Michihiro Yoshimura, et al.
Published: (2010-06-01)

The renin-angiotensin-aldosterone system and fibrinolysis
by: Dirk C Felmeden, et al.
Published: (2000-09-01)

Gene polymorphisms of angiotensin-converting enzyme, angiotensin type 1 receptor and ⁪⁯α-adducin associated with renin angiotensin-aldosterone system in Malaysian end-stage renal disease patients
by: Ali, Aisyah
Published: (2012)

Review: The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors
by: Domenic A Sica
Published: (2002-06-01)

The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients
by: Amer Harky, et al.
Published: (2021-01-01)

Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis
by: Jin Sun Choi, et al.
Published: (2023-11-01)

Review: Renal protection by inhibition of the renin-angiotensin-aldosterone system
by: Tomas Berl
Published: (2009-03-01)

Effect of renal denervation on catecholamines and the renin–angiotensin–aldosterone system
by: Lida Feyz, et al.
Published: (2020-08-01)

Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance
by: Christophe Meune, et al.
Published: (2003-09-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
by: Andre Feldman, et al.
Published: (2020-11-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
by: Andre Feldman, et al.
Published: (2020-11-01)

Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials
by: Pınar Kızılırmak, et al.
Published: (2017-01-01)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
by: Marco Rossato, et al.
Published: (2020-07-01)

Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison
by: Nicolás Roberto Robles, et al.
Published: (2009-12-01)

Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients
by: Wissam Mekary, et al.
Published: (2023-09-01)

Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
by: James A. Ker
Published: (2015-05-01)

Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID‐19
by: Michael Pan, et al.
Published: (2021-12-01)

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality of Coronary Artery Bypass Grafting
by: Ahmad Sharafi, et al.
Published: (2015-10-01)

The Renin-Angiotensin-Aldosterone System and Metabolic Syndrome
by: Michel Burnier
Published: (2006-09-01)

Meta-analysis of effect of renin–angiotensin–aldosterone system blockers on contrast-induced nephropathy
by: Weidong Wang, et al.
Published: (2020-05-01)

Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus
by: Hans-Henrik Parving
Published: (2000-03-01)

Angiotensin converting enzyme inhibitors /
by: DeBrue, Anne N.
Published: (c200)

The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC
by: Babak Yazdani, et al.
Published: (2022-12-01)

Clinical and preclinical evidence that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prevent diabetic peripheral neuropathy
by: Shiori Iwane, et al.
Published: (2024-01-01)

Perioperative management of angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers: a survey of perioperative medicine practitioners
by: Sophie L.M. Walker, et al.
Published: (2018-06-01)

Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers on Acute Kidney Injury in Emergency Medical Admissions
by: Athanasios Feidakis, et al.
Published: (2021-01-01)

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction
by: Chih-Wei Chen, et al.
Published: (2023-01-01)

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction.
by: Chih-Wei Chen, et al.
Published: (2023-01-01)

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
by: Marie Douillard, MD, et al.
Published: (2023-08-01)

A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers
by: Seyed Ali Sadjadi, et al.
Published: (2009-07-01)

Angiotensin II generation in vivo: does it involve enzymes other than renin and angiotensin-converting enzyme?
by: Duncan J Campbell
Published: (2012-06-01)

Association of polymorphisms in angiotensin and aldosterone synthase genes of the renin–angiotensin–aldosterone system with high-altitude pulmonary edema
by: Swati Srivastava, et al.
Published: (2012-03-01)

RETRACTED: Role of renin-angiotensin-aldosterone system inhibitors in radiation nephropathy
by: Tian-Biao Zhou, et al.
Published: (2015-12-01)

Novel Class of Central Renin Angiotensin Aldosterone System Inhibitor: Firibastat
Published: (2022-05-01)

Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review
by: Filipe Ferrari, et al.
Published: (2021-04-01)